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INtroDUctIoN 
Prediabetes, is defined as impaired fasting glucose
(blood glucose level between 5.6mmol/L and 6.9m-
mol/L).1 Impaired fasting glucose (IFG) is an inter-
mediate stage in the natural history of disordered car-
bohydrate metabolism between normal glucose home-
ostasis and diabetes.2 IFG is a measure of disturbed
carbohydrate metabolism in the basal state.1 Individ-
uals with prediabetes are at increased risk of devel-
oping diabetes, diabetes complications and cardio-
vascular disease.2-4 The natural history of prediabetes
is variable, with about 25% progressing to diabetes,
50% remaining in the abnormal glycaemic state, and
25% reverting to normoglycaemia over an observa-
tional period of 3-5 years.4,5 In 2005-2006, the preva-
lence of prediabetes among adolescents in the United
States aged 12-19 years, using the ADA criteria was
13.1%.6 Reports of recent studies show that the in-
cidence of pre-diabetes is increasing in children.7
Type 1 diabetes (T1D) is a multifactorial disease
with a strong genetic component. It is characterized
by autoimmune destruction of pancreatic β cells. The
human leucocyte antigen (HLA) region is a cluster
of genes located within the major histocompatibility
complex (MHC) on chromosome 6p21.8 It is estimated
that HLA accounts for 40-50% of familial clustering
and the strongest genetic association with T1D is con-
ferred by HLA class II gene alleles.8 In addition to
MHC class II associations, other different genetic loci
contribute susceptibility to T1D.9 Examples include:
(1) the insulin (INS) VNTR (variable number tandem
repeats), 10 (2) the Arg620 Trp single nucleotide poly-
morphism (SNP) at PTPN22 (protein tyrosine phos-
phatase nonreceptor 22),11 (3) the noncoding SNPs
at IL2RA,12 (4) the variants in the CTLA4 locus.13 All
these T1D-associated genes are expressed in cells
with immune function, and all except INS have been
associated with other immune disorders.9 Two recent
genome-wide association studies have separately i-
dentified two loci that confer T1D risk. These loci are
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16p13 locus14 and Chr12q13 locus.9 The effect of the
insulin gene appears to vary with ethnicity, with lesser
effect in non-Caucasian population.15 By dephospho-
rylating and inactivating T-cell receptor-associated
Csk kinase, PTPN22 appears to be involved in pre-
venting spontaneous T-cell activation.16 These con-
siderations provide the link between the well-recog-
nized associations of type 1 diabetes with genetic fac-
tors. Thus, providing an explanation for the increased
incidence in some families, of the concordance rates
in monozygotic twins and the ethnic and racial dif-
ferences in prevalence rates.17,18
Although the risk of developing T1D is increased
in relatives of individuals with the disease, the risk is
relatively low. This risk depends on which HLA hap-
lotypes are shared.8 From multiple family pedigrees
and HLA typing data, it is estimated that if a sibling
shares both HLA D haplotypes with an index patient
the risk for that individual is 12% to 20%; for a sibling
sharing only one haplotype , the risk for T1D is 5%
to 7%; and with no haplotypes in common the risk is
only 1% to 2%.19 Indeed, Redondo et al,20 stated that
approximately 85% of new cases of T1D occur in per-
sons without an affected first-degree relative. Ap-
proximately 13% of children and adolescents who de-
velop T1D have a parent or sibling with diabetes.21
Dahiquist and Gothefors21 reported that among chil-
dren with newly diagnosed diabetes, 2-3% have a
mother with T1D, 5-6% have a father with T1D, and
4-5% have a brother or a sister with T1D. The study
of familial clustering is a central theme in genetic epi-
demiology. Familial clustering refers to the occurrence
of a disorder at a higher frequency in first-degree rel-
atives of an affected person compared to the general
population.22 One widely used measure of familial
clustering is the sibling recurrence risk ratio (s), which
is defined as the ratio of risk of disease manifestation,
given that one’s sibling is affected, as compared with
the disease prevalence in general population.22
The purpose of this paper is to report a case of a
Nigerian boy with T1D and whose three elder sisters
had impaired fasting blood glucose (prediabetes). It
is hoped that this report will encourage clinicians to
assess for prediabetes in siblings of children with type
1 diabetes. 
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The patient is 9-year old boy with a 3-day history of
polyuria and polydipsia.There was no significant weight
loss. His father is known have type 2 diabetes which
was diagnosed 17 years ago. He had been on oral glu-
cose-lowering agent for the first 10 years but switched
to insulin in the past 7 years because unsatisfactory
response to oral glucose-lowering agent. The ages of
the father and mother are 51 and 47 years, respectively.
Physical examination revealed weight 57kg (> 95th
percentile), height 160cm (> 95th percentile) and body
mass index, BMI 22.3kg/m2 (> 95th percentile). No a-
canthosis nigricans. External genital examination re-
vealed testicular volume 4ml bilaterally, stretched pe-
nile length 6cm and pubic hair Tanner stage 2. A di-
agnosis of a diabetes mellitus (newly diagnosed) was
made. Laboratory investigations confirmed that he
has type 1 diabetes mellitus. The laboratory findings
at initial diagnosis are summarized in Table 1. His el-
der sister who accompanied him to the laboratory for
fasting blood glucose (FBG) measurement decided
to check her own fasting blood glucose and the result
revealed that she has impaired fasting blood glucose
(FBG 6.1 mmol/L). This prompted the measurement
of FBG for his other two sisters. The laboratory find-
ings in the three elder sisters are summarized in Table
2. The BMI of the siblings are as follows: first sibling
BMI = 26kg/m2; second sibling BMI = 24kg/m2); and
third sibling BMI = 21kg/m2. The patient is the only
son of his parents. He is currently in his first year in
the Junior Secondary School. In relation to main
meals, he was placed on rapid-acting insulin (Lispro)
5 units, 6 units and 4 units in the morning, afternoon
and evening respectively. He also takes a long-acting
insulin (glargine) 20 units at bedtime, between 9-10
pm. Total daily dose of insulin is 0.6U/kg/day. With
this insulin regimen, the boy‘s diabetes is well con-
trolled with no hypoglycaemic episodes. Consent was
obtained from the parents of the patients. His blood
glucose range were FBG 4.8-6.7mmolL; prelaunch
BG 4.3-6.9mmol/L and pre-dinner BG 4.1-6.4mmol/L.
He is being followed up in the outpatient clinic. Other
initial laboratory findings are summarized in Table
1. The three siblings of the index patient are currently
being followed up with periodic retesting, using fasting
and/or 2-hour postprandial blood glucose.
The age and laboratory findings in the three sisters
of the index patient is summarized in Table 2 and it
shows that their fasting blood glucose levels were in
the prediabetic range.
DIscUssIoN
In the index patient, the diagnosis of type 1 diabetes
mellitus (T1DM) was based on the presence of clas-
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sical symptoms of diabetes mellitus, fasting hypergly-
caemia (20.5mmol/L), elevated HbA1C (9.9%), and
low C-peptide level. These findings are in keeping
with the most recent International Society of Pediatric
and Adolescent Diabetes (ISPAD) established criteria
for the diagnosis of type 1 diabetes.1 In addition, with
insulin therapy, the boy‘s diabetes was well controlled
with no hypoglycaemic episodes. The fasting blood
glucose levels in the three elder sisters of the index
patient were abnormal and met the most recent IS-
PAD and American Diabetes Association (ADA) cri-
teria for the diagnosis of prediabetes (impaired fasting
blood glucose).1,2
The presence of prediabetes in the three sisters
of the index patient is an interesting finding. This im-
plies that all the four children in this family have an
abnormal carbohydrate metabolism. The clinical im-
plication is two folds. First, the three sisters are at in-
creased risk of developing diabetes, diabetes compli-
cations and cardiovascular disease.2 Secondly, the p-
resentation of familial form of mild diabetes during
adolescence should raise the suspicion of monogenic
diabetes (maturity onset diabetes of the young;
MODY), which accounts for 1-4% of paediatric dia-
betes cases.23,24 As stated in ISPAD guideline, it is ap-
propriate to always define monogenic diabetes by its
genetic subgroups.1 The benefits of making a specific
molecular diagnosis include prediction of expected
clinical course of the disease and guiding individual
case management. In addition, such specific molecular
diagnosis has important implications for family mem-
bers by promoting genetic counselling and extended
genetic testing in other family members and this may
lead to reclassification of their type of diabetes.25
However, we could not investigate the siblings of the
patient for monogenic diabetes because of inadequate
of laboratory facilities in the setting where we practice.
This represents one of the challenges of management
of such clinical condition in resource-limited countries.
The parents of these children declined oral glucose
tolerance test (OGTT) for their daughters because
of the fear that it could worsen their daughters’ clinical
condition. We, therefore, continued follow up with
periodic retesting, using fasting and/or 2-hour post-
prandial blood glucose level determinations as sug-
gested in ISPAD recent guideline.1 The father of these
children is known to have type 2 diabetes which was
diagnosed 17 years ago (at the age of 34 years). His
blood glucose was initially controlled on oral glucose-
lowering agent for the first 10 years but had to switch
to insulin in the last 7 years because of unsatisfactory
glycaemic control while on oral glucose-lowering
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table 1. Summary of laboratory findings at initial diagnosis.
Laboratory parameter Results Normal limits Comments
Fasting blood glucose 20.5 mmol/L 3.0-6.1 mmol/L Very high
HbAIC 9.9% 4.0-5.6% Very high
Plasma triglyceride 15.23 mmol/L 0.31-1.08 mmol/L Very high
Total serum cholesterol 7.45 mmol/L 3.11-5.16 mmol/L High
C-peptide 183 pmol/L 364-1655 pmol/L Low
GAD autoantibodies <5IU/ml 0-10 Negative
IA-2 autoantibodies < 10IU/ml 0-20 Negative
GAD =  glutamic acid decarboxylase   IA-2 = Insulinoma-associated protein-2
table 2. Summary of laboratory findings in three siblings of the index patient.
Laboratory parameter Age (years) Results Comments
Fasting blood glucose
Sibling 1 21 6.1 mmol/L Pre-diabetic value
Sibling 2 18 5.9 mmol/L Pre-diabetic value
Sibling 3 15 5.6 mmol/L Pre-diabetic value
HbA1C value 
Sibling 1 21 5.9% Pre-diabetic value
Sibling 2 18 5.8% Pre-diabetic value
Sibling 3 15 5.6% Just below pre-diabetic value
1. Craig ME, Jefferies C, Dabelea D, Balde N, Seth A,
Donaghue KC. Definition, epidemiology and classifica-
tion of diabetes in children and adolescents. Pediatr Di-
abetes 2014;15(Suppl 20):4-17.
2. American Diabetes Association. Diagnosis and classifi-
cation of diabetes mellitus. Diabetes Care 2014;37(Suppl
1):S81-S90. 
3. Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivi-
maki M. Pre-diabetes: a high-risk state for diabetes de-
velopment. Lancet 2012;379:2279-2290. 
4. Grundy SM. Pre-diabetes, metabolic syndrome, and car-
diovascular risk. J Am Coll Cardiol 2012;59:635-643. 
5. Gabir MM, Hanson RL, Dabetea D, Imperatore G,
Roumain J, Binnett PH, Knowler WC. The 1997 Amer-
ican Diabetes Association and 1999 World Health Or-
ganization criteria for hyperglycemia in the diagnosis
and prediction of diabetes. Diabetes Care 2000;23:1108-
1112. 
6. Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chit-
son P, Gareeboo H, Hemraj F, Fareed D, Toumilhto J,
Alberti KG. Impaired fasting glucose or impaired glucose
tolerance: what best predicts future diabetes in Mauritus?
Diabetes Care 1999;22:399-402.
7. Li C, Ford ES, Zhao G, Mokdad AH. Prediabetes and
its association with clustering of cardiometabolic risk
factors and hyperinsulinaemia among US adolescents:
National Health and Nutrition Examination Survey 2005-
2006. Diabetes Care 2009;32:342-347.
8. Pociot F, McDermott MF. Genetics of type 1 diabetes
mellitus. Genes Immunity 2002;3:235-249. 
9. Hakonarson H, Qu HQ, Bradfield JP, Marchand L, Kim
CE, Glessner JT et al. A novel susceptibility locus for
type 1 diabetes on Chr 12q13 identified by a genome-
Wide Association Study. Diabetes 2008;57:1143-1146. 
10. Barrat BJ, Payne F, Lowe CE, Hermann R, Healy BC,
Harold D, et al. Remapping the insulin gene/IDDM2
locus in type 1 diabetes. Diabetes 2004;53:1884-1889.
11. Bottini N, Vang T, Cucca F, Mustelin T. Role of PTPN22
in type 1 diabetes and other autoimmune diseases. Semin
Immunol 2006;18:207-213.
12. Qu HQ, Montpetit A, Ge B, Hudson TJ, Polychronakos
C. Toward further mapping of the association between
the IL2RA locus and type 1 diabetes. Diabetes
2007;56:1174-1176. 
13. Ueda H, Howson JM, Esposito L, Heward J, Snook H,
Chamberlain G, Rainbow DB et al. Association of the
agent. Such switch from oral glucose-lowering agent
to insulin therapy is a well documented phenomenon
in the management of adulthood type 2 diabetes
(T2D).26 This switch in therapy is because of the pro-
gressive nature of T2D and the relative insulin defi-
ciency that develops in individuals with long-standing
diabetes mellitus.
Some of the risk factors for type 1 diabetes (T1D)
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